SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Remedium Lifecare surges on planning to increase borrowing limit by issuance of debt securities

15 Jun 2023 Evaluate

Remedium Lifecare is currently trading at Rs. 2908.10, up by 57.70 points or 2.02% from its previous closing of Rs. 2850.40 on the BSE.

The scrip opened at Rs. 2840.60 and has touched a high and low of Rs. 2949.95 and Rs. 2838.00 respectively. So far 854 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 3139.60 on 14-Jun-2023 and a 52 week low of Rs. 134.50 on 20-Jun-2022.

Last one week high and low of the scrip stood at Rs. 3139.60 and Rs. 2260.00 respectively. The current market cap of the company is Rs. 1046.92 crore.

The promoters holding in the company stood at 1.11%, while Non-Institutions held 98.89% stake in the company.

Remedium Lifecare is planning to increase borrowing limit from Rs 50 crore to Rs 1000 crore by issuance of debt securities ie. Non -Convertible Debentures(NCD), Bank Term Loans etc. The company is also planning to consider and approve limit for investment by way of acquisition of Asset such as Plant &, Machinery, securities, etc upto Rs 1000 crore. The meeting of the Board of Directors of the Company is scheduled to be held on June 23, 2023 to consider the same.          

Remedium Lifecare is pharmaceutical company aligned across two business verticals viz. Products and Services.

Supha Pharmachem Share Price

0.48 0.00 (0.00%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 216.75
Adani Enterprises 2282.00
Amrapali Industries 17.70
Rashi Peripheral 461.50
PDS 280.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×